Aurora Pharmaceutical Receives FDA Approval on Altren®

Aurora Pharmaceutical announces the FDA approval of Altren™, an altrenogest oral progestin solution for horses.
Share
Favorite
Close

No account yet? Register

ADVERTISEMENT

FOR IMMEDIATE RELEASE

Aurora Pharmaceutical receives FDA approval on Altren™, an altrenogest oral progestin solution for horses.

July 26, 2017–Altren (altrenogest) Solution 0.22% (2.2 mg/ml) is manufactured in Northfield Minnesota in an FDA licensed facility using the same formulation as Regu-Mate®.

Altren (altrenogest) Solution 0.22% is indicated to suppress estrus in mares. Suppression of estrus allows for a predictable occurrence of estrus following drug withdrawal. Altren (altrenogest) is administered orally at 1 mL per 110 pounds’ body weight (0.044 mg/kg) once daily for 15 consecutive days. Administer solution directly on the base of the mare’s tongue or on the mare’s usual grain ration

Create a free account with TheHorse.com to view this content.

TheHorse.com is home to thousands of free articles about horse health care. In order to access some of our exclusive free content, you must be signed into TheHorse.com.

Start your free account today!

Already have an account?
and continue reading.

Share

Written by:

Product and information releases by various organizations and companies.

Related Articles

Stay on top of the most recent Horse Health news with

FREE weekly newsletters from TheHorse.com

Sponsored Content

Weekly Poll

sponsored by:

When do you vaccinate your horse?
387 votes · 387 answers

Readers’ Most Popular

Sign In

Don’t have an account? Register for a FREE account here.

Need to update your account?

You need to be logged in to fill out this form

Create a free account with TheHorse.com!